Asia Pacific Fed. Pharmacologists

Home / Asia Pacific Fed. Pharmacologists

Asia Pacific Federation of Pharmacologists

The Asia Pacific Federation of Pharmacologists includes the pharmacological societies (and their members) of countries that lie between longitudes 90° and 180º east of Greenwich.

The APFP defines pharmacology broadly as comprising pharmacology, clinical pharmacology, toxicology and clinical toxicology, and branches of pharmacology such as pharmacogenomics. It also includes the scientific study of traditional medicines and natural products with pharmacological activity, areas in which the region has a rich tradition.

Formerly known as SEAWP-RFP the organisation was founded by Professors Koroku Hashimoto (Japan) and Michael Rand (Australia) in 1972. Professors Hashimoto and Rand served as the first two presidents of the Federation (from 1976-2001). Professor Rand was succeeded as president by Professor Masao Endoh (2002-2007). The current president is Professor John Miners. The Federation held its first Regional Scientific Meeting, under the auspices of the International Union of Basic and Clinical Pharmacology (IUPHAR;, in Singapore in 1976. Statutes were drafted and adopted during the 8th Regional Meeting (Taipei, 1999), and the SEAWP-RFP was formally affiliated with IUPHAR in 2001.

Member societies

Membership is available to pharmacological societies in the Asia Pacific region that are affiliated to IUPHAR, and is contingent on the vote of the membership of each Society in accord with its statues to join the Federation. Each member of an affiliated Society automatically becomes a member of the Federation. The Federation has no authority to intervene in the internal affairs of member societies unless requested by a majority of the membership of that Society.

Current member societies include:

• Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) (
• Chinese Pharmacological Society (
• Indonesian Pharmacological Association
• Japanese Pharmacological Society (JPS) (
• Korean Society of Pharmacology (
• Malaysian Society of Pharmacology and Physiology
• Pharmacological Society in Taiwan
• Pharmacological and Therapeutics Society of Thailand
• Philippine Society of Experimental and Clinical Pharmacology

Individual membership may be granted to pharmacologists in parts of the region that do not have a pharmacological society affiliated with IUPHAR, provided that such persons undertake to work towards the formation of a local Society and eventually its affiliation with IUPHAR.

Corporate membership is available to commercial and government organisations operating within the region.

Member societies pay an annual subscription to the Federation based on a scale designated by IUPHAR.

Asia Pacific Federation Objectives

• The advancement of research, teaching and community service in pharmacology
• The fostering of cooperation between Pharmacological Societies and pharmacologists in the region
• Encouragement of the formation of special interest groups in areas of pharmacology that are of interest and significance to the region
• Encouragement of free association between pharmacologists of the region, including the holding of regional meetings on a regular basis
• Liaison with relevant international organisations, particularly IUPHAR
• Liaison with other relevant biomedical organisations in the region and in the Pacific rim (e.g. the Western Pharmacological Society)


The Executive Committee and Council of the Federation hold office for the period between regional meetings and conduct the affairs of the Federation during that time. The Executive Committee is elected at the Business Meeting of each Regional Meeting by a majority vote of the representatives of the member societies and is comprised of the President, 1st Vice-President (President-elect) and Secretary-General/Treasurer (2nd Vice-President). All past presidents become emeritus members of the Executive.

The Council includes a nominee of each member society, generally the President, and has responsibility for maintaining the relationship between the member societies and the Federation. Council may also co-opt members from member societies, especially the convenors of future meetings, although a member society is limited to two positions on Council.

Executive 2012-2015

President – – Professor Samuel HH Chan, Distinguished Chair Professor and Director, Center for Translational Research in Biomedical Sciences, Chang Gung Memorial Hospital – Kaohsiung Medical Center, Taiwan (

1st Vice-President (President-elect) – Professor Masayoshi Mishina, Molecular Neurobiology and Pharmacology, Graduate School of Medicine, University of Tokyo, Japan (

Secretary General/Treasurer – Professor Alastair Stewart, Department of Pharmacology, University of Melbourne, Australia (

Emeritus member (past-President) – Professor John Miners, Clinical Pharmacology, Flinders University School of Medicine, Flinders Medical Centre, Adelaide, Australia (

Council 2012-2015

Professor Nafeeza Mohd Ismail, Malaysian Society of Pharmacology and Physiology
Professor Wen-Chang Chang, Pharmacological Society of Taiwan
Professor Guan-Hua Du, Chinese Pharmacological Society
Professor Masamitsu Iino, Japanese Pharmacological Society
Associate Professor Peter Molenaar, Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists
Professor Zhi-Bin Lin, Chinese Pharmacological Society (Organiser of the 12th APFP Meeting)
Professor Dong Goo Kim, Korean Society of Pharmacology
Associate Professor Supratra Srichairat, Pharmacological and Therapeutics Society of Thailand

Regional Meetings of Pharmacologists

Meetings are held every three to four years. Federation sponsored workshops and other meetings are encouraged in the intervening years. Venues, years and organisers of previous meetings are given below:

• 12th meeting 2013 – Shanghai, China
• 11th Meeting – Japan, 2011. Hosted by the Japanese Pharmacological Society
(cancelled due to the earthquake/tsunami)
• 10th Meeting, 2007, Adelaide, Australia (Chair – John O. Miners). Host Society, Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists
• 9th Meeting, 2003, Busan, South Korea (Chair – Kyung Hwan Kim). Host Society, Korean Society of Pharmacology.
• 8th Meeting, 1999, Taiwan (Co-Chairs – Che-Ming Teng and Samuel HH Chan). Host Society, Pharmacological Society in Taiwan
• 7th Meeting, 1995, Manila, the Philippines (Chair – Esperanza I. Cabral). Host Society, Philippines Society of Experimental and Clinical Pharmacology
• 6th Meeting, 1991, Hong Kong (Chair – Clive W. Ogle). Host Society, Hong Kong Pharmacology Society
• 5th Meeting, 1988, Beijing, China (Chair – Wang Zhen-Gang). Host Society, Chinese Pharmacological Society
• 4th Meeting, 1985, Bangkok, Thailand (Chair – Chiravat Sadavongvivad). Host Society, Pharmacological and Therapeutics Society of Thailand
• 3rd Meeting, 1982, Penang, Malaysia
• 2nd Meeting, 1979, Indonesia
• 1st Meeting, 1976, Singapore

Future Federation Meetings

13th Meeting, February, Thailand, 2016. Hosted by the Pharmacological and Therapeutics Society of Thailand

Travel grant application forms for assistance to attend the APFP meeting can be downloaded here.


What’s new

The June issue of Pharmacology International, the newsletter of the International Union of Basic and Clinical Pharmacology (IUPHAR), offers comprehensive information about Cape Town and the 17th World Congress of Basic and Clinical Pharmacology (, scheduled July 13-18, 2014. In addition to superb scientific symposia and satellite meetings (registration is still available), the WCP2014 organizers offer you some history of what it took to bring pharmacology and an IUPHAR congress to the African continent.

Also featured are updates from various IUPHAR affiliates and members. In particular, we congratulate the Hellenic Society of Basic and Clinical Pharmacology on its 30th anniversary and pay tribute to the recipients of the BCPT Nordic Prize, the IUPHAR Education Section Early Educator Award, the PRACP Werner Kalow Responsible Innovation Prize in Global Omics and Personalized Medicine, and the BPS Drug Discovery of the Year.